Serum Institute of India

Serum Institute of India is a company that manufactures vaccines and other pharmaceutical products. The company was founded in 1996 in Pune, Maharashtra, India.

They have produced and sold over 1.5 billion doses of vaccines around the world. The company has manufacture vaccines for Polio, Diphtheria, Tetanus, Perussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella diseases.

COVID-19

The company has partnered with a US-based biotech drug research company, Codagenix, to develop a vaccine to fight the coronavirus. The company claims it is the first vaccine to move from the laboratory to pre-clinical trial phase and they expect the product to be ready by 2022.